NIRRIN TECHNOLOGIES INC

formerly Nirrin

Making Medicines Easier to Make

NIRRIN TECHNOLOGIES INC was founded in 2024, is headquartered in Billerica, United States, lists 1–10 employees, and has $15.2M in recorded funding across 2 rounds.

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$15.2M
Last Round
$6.7M Venture RoundJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Nirrin Technologies develops high-precision tunable laser spectroscopy (HPTLS) analytical systems for biopharma biomanufacturing. Their Atlas system provides at-line, in-line, and in-situ process analytical solutions for complex biologics and advanced therapies, enabling rapid measurement of product titer and buffer/excipient concentrations. The NIH awarded Nirrin a $2M grant to further develop its optical spectroscopy technique for rapid characterization of complex biomanufacturing processes.

Summary

NIRRIN TECHNOLOGIES INC is a Biotech company based in Billerica, United States, founded in 2024. It lists 1–10 employees. It has raised $15.2M in total across 2 rounds, most recently a $6.7M Venture Round in Jun 2026. Investors include Anzu Partners and BioTools Innovator.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding RoundJun 2026
$6.7M

Sign up to see all 2 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NIRRIN TECHNOLOGIES INC on Indexed.vc
<a href="https://indexed.vc/companies/nirrin-technologies-inc"><img src="https://indexed.vc/api/badge/company/nirrin-technologies-inc" alt="NIRRIN TECHNOLOGIES INC on Indexed.vc" width="260" height="76" /></a>